News

GDUFA II FY18 Fees Posted

CMOs to see significant drop in user fee burden

Read the full news article

PBOA Praises Enactment of FDARA

August 18, 2017 – Ringwood, NJ – The Pharma & Biopharma Outsourcing Association (PBOA), a trade group that represents Contract Manufacturing Organizations (CMOs) and other service providers in the bio/pharmaceutical sector, is pleased that H.R. 2430, the FDA Reauthorization Act (FDARA), has been signed into law, renewing four major user fee agreements between industry and.

Read the full news article

PBOA Applauds Passage of FDA Reauthorization Act

August 3, 2017 – Ringwood, NJ – The Pharma & Biopharma Outsourcing Association (PBOA), a trade group that represents Contract Manufacturing Organizations (CMOs) and other service providers in the bio/pharmaceutical sector, is pleased that the U.S. Senate has unanimously consented to pass H.R. 2430, the FDA Reauthorization Act (FDARA). PBOA president Gil Roth issued the.

Read the full news article

PBOA Praises Congressional Action On FDA Reauthorization

HELP, E&C release discussion draft of User Fees Reauthorization

Read the full news article